asim farooq shizza fatima
DESCRIPTION
Molecular Diagnosis Of Infectious Diseases. Asim Farooq Shizza Fatima. Contents. Introduction Need, Advantages and Disadvantages SARS and its Diagnosis Pertussis and Viral Pneumonia and their Diagnosis. Infectious Disease. Clinically evident illness - PowerPoint PPT PresentationTRANSCRIPT
Asim Farooq Shizza Fatima
Molecular Diagnosis Of Infectious Diseases
Contents Introduction Need, Advantages and Disadvantages SARS and its Diagnosis Pertussis and Viral Pneumonia and their
Diagnosis
Infectious Disease Clinically evident illness Infection and presence of pathogenic agent in
host organism Sometimes contagious Viruses, Bacteria, Fungi, Protozoa,
Multicellular Parasites and Prions Primary and opportunistic pathogens
Molecular Diagnosis A technique of identifying organisms on the
basis of their genetic makeup Molecules specific to a particular organism Molecular sizes, structure, mass DNA, RNA and Proteins Cellular and molecular interactions
Why Molecular Diagnosis Need an accurate and timely diagnosisImportant for initiating the proper treatment
Important for preventing the spread of a contagious disease
Continued… Nonculturable agents
Human papilloma virus Hepatitis B virus
Fastidious, slow-growing agents Mycobacterium tuberculosis Legionella pneumophilia
Highly infectious agents that are dangerous to culture Francisella tularensis
Brucella species Coccidioidis immitis
Continued… In situ detection of infectious agents
Helicobacter pylori Toxoplasma gondii
Agents present in low numbers HIV at early stages
CMV in transplanted organsOrganisms present in small volume specimens
Intra-ocular fluid Forensic samples
Continued…
Molecular epidemiologyTo identify point sources for hospital and
community-based outbreaksTo predict virulence
Culture confirmation
Molecular TechniquesDirect probe testing – better for identification than
for detection because it is not as sensitive as amplification methods
Amplification methods – used to improve the sensitivity of the nucleic acid testing technique
Target amplificationProbe amplificationSignal amplification
Combinations of the above
Target Amplification
Target amplification requires that the DNA to be tested for be amplified, i.e., the number of copies of the DNA is increased.
AdvantagesHigh sensitivity
Can theoretically detect the presence of a single organism
High specificityCan detect specific genotypesCan determine drug resistance
Can predict virulenceSpeed
Quicker than traditional culturing for certain organisms
Continued…
SimplicitySome assays are now automated
DisadvantagesExpensiveSo specific that must have good clinical data to
support infection by that organism before testing is initiated.
Will miss new organisms unless sequencing is done as we will be doing in the lab for our molecular unknowns
May be a problem with mixed cultures – would have to assay for all organisms causing the infection.
Severe Acute Respiratory Syndrome SARS coronavirus Outbreak in China and Hong Kong in 2002 Flu, fever, myalgia, lethargy, cough, sore
throat, shortness of breath Positive-strand, enveloped RNA viruses 13 known genes and 14 known proteins Large pleomorphic spherical particles with
bulbous surface projections that form a corona
Molecular Diagnosis Viral selectionViral loads maximum in lower tract specimensAlso found in gastrointestinal tract and fecesSARS-CoV RNA has been detected in blood,
cerebrospinal fluid, urine, and tears Viruses obtained from different sources are then
subjected to RNA extraction and then amplification through PCR
RNA ExtractionTesting multiple specimens Nucleocapsid transcripts nuc and pol genes
Interpretation of Results For a positive result, repeat it again or repeat it with a
different genomic locus False-positive specimens can occur with poorly
designed primers A negative result from an infected patient could be
due to the presence of PCR inhibitors that co-purify with RNA, a poor quality specimen, or a specimen lacking virus
Negative PCR results for specimens from the upper respiratory tract could trigger sampling from the lower respiratory tract where the titers of virus are higher
Pertussis
An acute, highly contagious respiratory disease characterized by paroxysmal coughing that ends in a
loud whooping inspiration.
Definition
Bordetella pertussis, is a small, nonmotile gram-negative coccobacillus
nonmotile
gram-negative coccobacillus
Causative agent
Molecular Diagnosis
A study was carried out on 5 patients for molecular diagnosis of pertussis
Age of the patients ranged from 35 days to 3 months, and one patient was 13 years old.
The clinical histories of the five patients varied, but all had a cough and other respiratory symptoms.
Hematoxylin and eosin staining of lung tissues from the patients showed bronchopneumonia
Silver staining (Steiner's method) demonstrated coccobacilli in all patients, while Gram's staining showed gram-negative bacilli in only patients 2 and 4.
From the tissue specimen β-globin gene was amplified
Utilizing PCR technique
Each PCR mixture consisted of A 300 nM concentration of each primer10 μl of DNA extract High-fidelity PCR master mix (containing 1.5
mM MgCl2 and a 0.2 mM concentration of each deoxynucleoside triphosphate)
And an enzyme mixture of Taq and Tgo DNA polymerases in a 50-μl volume.
DENATURATION
• THE DNA WAS DENATURED FOR 3 MIN AT 94°C
ANNEALING
• THEN SUBJECTED TO 40 CYCLES OF AMPLIFICATION (94°C FOR 15 S, 60°C FOR 20 S, AND 72°C FOR 30 S)
EXTENSION
• FOLLOWED BY A FINAL EXTENSION OF 10 MIN AT 72°C
Steps of PCR
When DNAs extracted from clinical samples of lung tissue infected with
Bacillus anthracis Group A Streptococcus Group B Streptococcus Haemophilus influenzae Legionella pneumophila Staphylococcus aureus Streptococcus pneumoniae, or Yersinia pestis And from liver tissue infected with spotted-fever-
group Rickettsia
The IS481 PCR assay did not generate an amplicon.
THE IS481PCR ASSAY AMPLIFIED A 181-BP FRAGMENT FROM LUNG OR TRACHEA SPECIMENS FROM THE FIVE PATIENTS, SUGGESTING THAT EITHER B. PERTUSSIS OR B. HOLMESII WAS PRESENT.
Sequencing the 181-bp amplicons of the IS481 gene from the clinical isolates and the five patients.
Results of sequencing At nucleotide 100 in all five clinical isolates of B.
holmesii, a mixture of nucleotide bases C and A occurred, with C slightly more predominant than A.
In contrast, an A was always present at the same nucleotide position in all five patient and clinical isolates of B. pertussis.
An analysis of the sequence from the reverse strand confirmed that a mixture of nucleotide bases G and T occurred at the homologous position in all five B. holmesii isolates, while only a T occurred in theB. pertussis isolates and the five patient isolates.
The patient history and clinical information are beneficial in differentiating between B. holmesii and B. pertussis. Although B. holmesii is known to cause septicemia and, in some instances, respiratory illnesses in adolescents and adults, the respiratory illness caused by B. holmesii is mild compared with that caused by B. pertussis, and no deaths have been attributed to B. holmesii.
To quantify the amounts of DNA extracted from human tissues, a real-time assay to detect an 80-bp region of the human RNase P gene was performed
Results of PCR
The specific real-time pertussis toxin assay, which targets a single-copy gene, demonstrated that all specimens from the five patients were positive for B.
Results of diagnosis
Of the five patients diagnosed with B. pertussis infection in this study, the epidemiologic data support the PCR results for four who were in contact with ill family members
Patient 2 confirmed influenza case without an epidemiologic link but was determined to be infected with B. pertussis by PCR tests
Patient 4 presented as a presumed SIDS-related fatality; however, conventional and real-time PCR tests, an immunohistochemical assay, and an epidemiologic link to a known B. pertussis case established that the infant was infected with B. pertussis.
Viral Influenza
Influenza is a febrile illness characterized by fever; cough; upper respiratory symptoms including sore throat, rhinorrhea, and nasal congestion; and
systemic symptoms including headache, myalgia, and malaise that results in a significant number of hospitalizations in all age groups
Definition
Influenza virus is a negative-sense single-
stranded RNA virus
Belonging to the family Orthomyxoviridae
Antiviral agents
Specific antiviral agents such as M2 channel inhibitors (amantidine and rimantidine) or
NA inhibitors (oseltamivir and zanamavir) can be prescribed; however, these drugs are effective only when given within the first 24 h following infection.
Diagnostic approaches
Serological tests such as the HAI test have been used to detect seroconversion of influenza virus
Nasopharyngeal swabs and NPA are the preferred specimens for influenza virus detection
Isolation of influenza virus was historically performed in embryonated hen eggs or tube cultures of primary monkey kidney, Madin-Darby canine kidney (MDCK), or A549 cells. CPE consistent with influenza virus can be visualized by light microscopy
Molecular diagnosis
Molecular tests for influenza virus detection include
Reverse transcriptase PCR (RT-PCR) NASBA LAMP
RT-PCR
In the case of RT-PCR, nucleic acid is reverse transcribed into cDNA using virus-specific oligonucleotide primers
Several different gene targets have been used for amplification including the matrix, HA, and NS protein genes
NASBA(Nucleic acid sequence based amplification)
A primer-dependent technology that can be used for the continuous amplification of nucleic acids in a single mixture at one temperature.
Working RNA template is given to the reaction mixture, the first
primer attaches to its complementary site at the 3' end of the template
Reverse transcriptase synthesizes the opposite, complementary DNA strand
RNAse H destroys the RNA template (RNAse H only destroys RNA in RNA-DNA hybrids, but not single-stranded RNA)
the second primer attaches to the 5' end of the DNA strand T7 RNA polymerase produces a complementary RNA strand
which can be used again in step 1, so this reaction is cyclic.
LAMP(Loop mediated isothermal amplification)
LAMP is a novel approach to nucleic acid amplification which uses a single temperature incubation thereby obviating the need for expensive thermal cyclers.
Uses
Particularly useful method for infectious disease diagnosis in low and middle income countries
In LAMP, the target sequence is amplified at a constant temperature of 60 - 65 °C using either two or three sets of primers and a polymerase with high strand displacement activity in addition to a replication activity
Typically, 4 different primers are used to identify 6 distinct regions on the target gene, which adds highly to the specificity